Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Review of Anticancer Therapy
List of Issues
Volume 21, Issue 12

Expert Review of Anticancer Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Anticancer Therapy, Volume 21, Issue 12 (2021)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 21, Issue 12 (2021)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer

William T. Tran, Fang-I Lu & Roberto Salgado

Pages: 1299-1301

Published online: 24 Jul 2021

First Page PreviewforTumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer | Full Text | References | PDF (154.9 KB) | EPUB

1703 Views
1 CrossRef citations
0Altmetric

Free Access

Drug Profile

Article

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan

Anna R Schreiber, Michelle Andress & Jennifer R Diamond

Pages: 1303-1311

Published online: 22 Oct 2021

AbstractforTackling metastatic triple-negative breast cancer with sacituzumab govitecan | Full Text | References | PDF (1.1 MB) | EPUB

4454 Views
5 CrossRef citations
0Altmetric

Open Access

Article

Evaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma

Nausheen Ahmed & Mehdi Hamadani

Pages: 1313-1320

Published online: 17 Oct 2021

AbstractforEvaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma | Full Text | References | PDF (337.1 KB) | EPUB

366 Views
0 CrossRef citations
0Altmetric

Article

Pembrolizumab in the first-line treatment of advanced head and neck cancer

Luana Guimaraes de Sousa & Renata Ferrarotto

Pages: 1321-1331

Published online: 02 Nov 2021

1417 Views
6 CrossRef citations
0Altmetric

Review

Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem

Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi & Alba Ariela Brandes

Pages: 1333-1353

Published online: 15 Nov 2021

AbstractforEngineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem | Full Text | References | PDF (1.8 MB) | EPUB

892 Views
6 CrossRef citations
0Altmetric

Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy

Sadra Behrouzieh, Fateme Sheida & Nima Rezaei

Pages: 1355-1370

Published online: 08 Nov 2021

AbstractforReview of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy | Full Text | References | PDF (938.7 KB) | EPUB

345 Views
4 CrossRef citations
0Altmetric

Novel therapeutic drug strategies to tackle immune-oncological challenges faced by cancer patients during COVID-19

Anwar Ali, Hafsa Mughal, Nazir Ahmad, Quratulain Babar, Ayesha Saeed, Waseem Khalid, Hasnain Raza & Aizhong Liu

Pages: 1371-1383

Published online: 22 Oct 2021

AbstractforNovel therapeutic drug strategies to tackle immune-oncological challenges faced by cancer patients during COVID-19 | Full Text | References | PDF (3.9 MB) | EPUB

300 Views
6 CrossRef citations
0Altmetric

Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy

Muhammad Sohail, Zheng Sun, Yanli Li, Xuejing Gu & Hui Xu

Pages: 1385-1398

Published online: 01 Nov 2021

AbstractforResearch progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy | Full Text | References | PDF (1.7 MB) | EPUB

888 Views
10 CrossRef citations
0Altmetric

Systematic Review

Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review

Shanshan Chen, Yanhong Ren, Huaping Dai, Yiqun Li, Bo Lan & Fei Ma

Pages: 1399-1410

Published online: 02 Nov 2021

362 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view

Frederick W Thielen, Marie-José Kersten, Pim Kuizenga, Mels Hoogendoorn, Eduardus FM Posthuma, Wendy BC Stevens, Carin A Uyl-de Groot & Hedwig M Blommestein

Pages: 1411-1422

Published online: 02 Sep 2021

2157 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Evaluating the efficacy and safety of trebananib in treating ovarian cancer and non-ovarian cancer patients: a meta-analysis and systematic review

Jialin Zhang et al.

Review Article | Published online: 5 Jul 2024

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Lorenzo Foffano et al.

Comment | Published online: 1 Jul 2024

First-in-human clinical trial results with ABBV-184, a first-in-class T-cell Receptor/Anti-CD3 bispecific protein, in adults with Previously treated AML or NSCLC

Pierre Peterlin et al.

Article | Published online: 1 Jul 2024

2024 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma

Viria Beccia et al.

Meeting Report | Published online: 27 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Anticancer Therapy (Vol.21, Iss.12, 2021)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?